{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:11:16Z","timestamp":1780668676332,"version":"3.54.1"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chronic spontaneous cholinergic urticaria (CSU-Chol) is a chronic inflammatory skin disorder characterized by intense pruritus and small wheals triggered by a rise in core body temperature. This review aims to systematically elucidate its complex pathogenesis, with a particular focus on the pivotal role of neuro-immune crosstalk in disease initiation and progression. We will provide an in-depth analysis of key immunological components, including aberrant mast cell activation, autoimmune responses, and dysregulation of the cytokine network. Furthermore, the review will detail how neuropeptides released from sensory nerve endings engage in dialogue with the immune system. Building on this mechanistic foundation, the article will further delineate the evolution of treatment strategies, from traditional antihistamines to emerging targeted therapies aimed at pathways involving IgE, IL-4\/IL-13, and mast cell signaling. The overarching goal is to consolidate current knowledge to provide a theoretical basis for precise clinical diagnosis and management, while highlighting promising future research directions for this challenging condition.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1848638","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:14:41Z","timestamp":1780665281000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic spontaneous cholinergic urticaria: advances in immunological mechanisms focusing on neuro-immune crosstalk and novel targeted therapeutic strategies"],"prefix":"10.3389","volume":"17","author":[{"given":"Meilv","family":"Yang","sequence":"first","affiliation":[{"name":"Rheumatology and Immunology Department, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, The Third Affiliated Hospital of Shanghai University, Wenzhou People\u2019s Hospital","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxian","family":"Lin","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, The Third Affiliated Hospital of Shanghai University, Wenzhou People\u2019s Hospital","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, The Third Affiliated Hospital of Shanghai University, Wenzhou People\u2019s Hospital","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanzhi","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of General Practice, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, The Third Affiliated Hospital of Shanghai University, Wenzhou People\u2019s Hospital","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Practice, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, The Third Affiliated Hospital of Shanghai University, Wenzhou People\u2019s Hospital","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, The Third Affiliated Hospital of Shanghai University, Wenzhou People\u2019s Hospital, The Wenzhou People\u2019s Hospital Affiliated of Hangzhou Medical College","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2023.06.033","article-title":"Chronic urticaria and angioedema: Masqueraders and misdiagnoses","volume":"11","author":"Bernstein","year":"2023","journal-title":"J Allergy Clin Immunol In Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16562","article-title":"A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan","volume":"49","author":"Saito","year":"2022","journal-title":"J Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/00099228241280531","article-title":"Chronic urticaria in children: A single-center retrospective study from Turkey","volume":"64","author":"Topkarci","year":"2025","journal-title":"Clin Pediatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.31744\/einstein_journal\/2020ao5175","article-title":"Chronic inducible urticaria: Confirmation through challenge tests and response to treatment","volume":"18","author":"Pereira","year":"2020","journal-title":"Einstein (Sao Paulo Brazil)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/cea.70215","article-title":"Diagnostic delay in patients with chronic urticaria: Results from the chronic urticaria registry (CURE)","volume":"56","author":"Mu\u00f1oz","year":"2026","journal-title":"Clin Exp Allergy: J Br Soc For Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19637","article-title":"A comparative analysis of chronic inducible urticaria in 423 patients: Clinical and laboratory features and comorbid conditions","volume":"38","author":"Ozdemir","year":"2024","journal-title":"J Eur Acad Dermatol Venereology: JEADV"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2024.1487831","article-title":"Key differences between chronic inducible and spontaneous urticaria","volume":"5","author":"Bizjak","year":"2024","journal-title":"Front Allergy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000507218","article-title":"Urticaria: Collegium internationale allergologicum (CIA) update 2020","volume":"181","author":"Maurer","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000536579","article-title":"Unveiling treatment response predictors in predominant subtypes of chronic inducible urticaria","volume":"185","author":"Ozdemir","year":"2024","journal-title":"Int Arch Allergy Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1584771","article-title":"Chronic inducible urticaria - having more than one is common and clinically relevant","volume":"16","author":"Lebedkina","year":"2025","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-020-04675-3","article-title":"Treatment of simultaneously occurring urticaria and atopic dermatitis with dupilumab","volume":"72","author":"F\u00f6hr","year":"2021","journal-title":"Der Hautarzt; Z Fur Dermatologie Venerologie Und Verwandte Gebiete"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jaci.2021.12.772","article-title":"An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria","volume":"149","author":"Altrichter","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.15570\/actaapa.2020.29","article-title":"Chronic inducible urticaria: Classification and prominent features of physical and non-physical types","volume":"29","author":"Pozderac","year":"2020","journal-title":"Acta Dermatovenerologica Alpina Pannonica Et Adriatica"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30869","article-title":"Cholinergic urticaria: A case report","volume":"14","author":"Fonseca","year":"2022","journal-title":"Cureus"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15261","article-title":"An evaluation of the factors affecting the clinical and laboratory findings, prognosis, and treatment response in children with chronic urticaria","volume":"35","author":"\u00d6zen","year":"2022","journal-title":"Dermatologic Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2022.01.003","article-title":"Clinical and histological characterization of transient dermal pain triggered by sweating stimuli","volume":"71","author":"Takahagi","year":"2022","journal-title":"Allergology International: Off J Japanese Soc Allergology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40257-022-00728-6","article-title":"Cholinergic urticaria: Subtype classification and clinical approach","volume":"24","author":"Fukunaga","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.12932\/AP-110625-2092","article-title":"Diagnostic performance and methodological concordance of the autologous sweat skin test for sweat allergy in a tropical setting: A pilot cross-sectional study","volume":"43","author":"Paringkarn","year":"2025","journal-title":"Asian Pacific J Allergy Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.alit.2020.05.006","article-title":"Direct and indirect action modes of acetylcholine in cholinergic urticaria","volume":"70","author":"Tokura","year":"2021","journal-title":"Allergology International: Off J Japanese Soc Allergology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2024.11.004","article-title":"Detection of anti-MGL_1304 IgE using the ImmunoCAP system for diagnosis of type i allergy to sweat","volume":"74","author":"Takahagi","year":"2025","journal-title":"Allergology International: Off J Japanese Soc Allergology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.3390\/ijms25094658","article-title":"Altered sweat composition due to changes in tight junction expression of sweat glands in cholinergic urticaria patients","volume":"25","author":"Daci","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jaip.2024.10.011","article-title":"Validation of the cholinergic urticaria activity score (CholUAS)","volume":"13","author":"Schnarkowski","year":"2025","journal-title":"J Allergy Clin Immunol In Pract"},{"key":"B23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11882-025-01215-8","article-title":"Autoallergy and what the Allergist Needs to know","volume":"25","author":"Steinert","year":"2025","journal-title":"Curr Allergy Asthma Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2025.07.025","article-title":"Pathogenesis of chronic spontaneous urticaria with or without angioedema","volume":"13","author":"Saini","year":"2025","journal-title":"J Allergy Clin Immunol In Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880412","article-title":"IgG autoantibodies against IgE from atopic dermatitis can induce the release of cytokines and proinflammatory mediators from basophils and mast cells","volume":"13","author":"Poto","year":"2022","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/antib13030058","article-title":"A comparison of natural and therapeutic anti-IgE antibodies","volume":"13","author":"Vogel","year":"2024","journal-title":"Antibodies (Basel Switzerland)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","article-title":"Urticaria","volume":"8","author":"Kolkhir","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.04.010","article-title":"Autoimmune chronic spontaneous urticaria","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.alit.2021.08.007","article-title":"A novel detection method for cross-linking of IgE-receptors by autoantibodies in chronic spontaneous urticaria","volume":"71","author":"Koga","year":"2022","journal-title":"Allergology International: Off J Japanese Soc Allergology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-023-01117-7","article-title":"Biomarkers of autoimmune chronic spontaneous urticaria","volume":"23","author":"Larenas-Linnemann","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.15568","article-title":"Chronic spontaneous urticaria: A review","volume":"332","author":"Kolkhir","year":"2024","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.jaip.2023.02.006","article-title":"Most patients with autoimmune chronic spontaneous urticaria also have autoallergic urticaria, but not ViceVersa","volume":"11","author":"Xiang","year":"2023","journal-title":"J Allergy Clin Immunol In Pract"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13428","article-title":"Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria","volume":"200","author":"Asero","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0140-6736(24)00852-3","article-title":"Chronic urticaria: Unmet needs, emerging drugs, and new perspectives on personalised treatment","volume":"404","author":"Zuberbier","year":"2024","journal-title":"Lancet (London England)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/cea.70100","article-title":"Towards personalised therapy in chronic spontaneous urticaria: Advancing from endotype to clinical response","volume":"55","author":"Ridge","year":"2025","journal-title":"Clin Exp Allergy: J Br Soc For Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2022.2122055","article-title":"Asian herbal medicine and chronic urticaria: Which are the therapeutic perspectives","volume":"37","author":"Gammeri","year":"2023","journal-title":"Nat Prod Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12227","article-title":"Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of Fc\u03f5R1 expression level and omalizumab clinical response","volume":"13","author":"Gimeno","year":"2023","journal-title":"Clin Trans Allergy"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.879754","article-title":"The role of crosstalk of immune cells in pathogenesis of chronic spontaneous urticaria","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2025.1728559","article-title":"Predictors of early treatment response to antihistamines and omalizumab in chronic spontaneous urticaria","volume":"6","author":"Calzari","year":"2025","journal-title":"Front Allergy"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-024-01538-y","article-title":"Senso-immunology: The hidden relationship between sensory system and immune system","volume":"42","author":"Miyamoto","year":"2024","journal-title":"J Bone Miner Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.612480","article-title":"Beyond neuronal heat sensing: Diversity of TRPV1 heat-capsaicin receptor-channel functions","volume":"14","author":"Shuba","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.3390\/ijms22094421","article-title":"The multifaceted mas-related g protein-coupled receptor member X2 in allergic diseases and beyond","volume":"22","author":"Quan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.027","article-title":"Mas-related g protein-coupled receptor X2 and its activators in dermatologic allergies","volume":"147","author":"K\u00fchn","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"104728","DOI":"10.1016\/j.cellimm.2023.104728","article-title":"Paeonol attenuates substance P-induced urticaria by inhibiting Src kinase phosphorylation in mast cells","author":"Ding","year":"2023","journal-title":"Cell Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/idoj.idoj_415_25","article-title":"The neuropsychological dimensions to pathogenesis of chronic spontaneous urticaria beyond autoallergy - a brief narrative review","volume":"17","author":"Kumaran","year":"2026","journal-title":"Indian Dermatol Online J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8087274","article-title":"Effects of omalizumab on serum levels of substance p, calcitonin gene-related peptide, neuropeptide y, and interleukin-31 in patients with chronic spontaneous urticaria","volume":"2023","author":"Boyvadoglu","year":"2023","journal-title":"Mediators Inflammation"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1645095","article-title":"Mast cell-neuron axis as a core mechanism in chronic pruritus of atopic dermatitis: From mechanistic insights to therapeutic targets","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100976RR","article-title":"The widely used antihistamine mepyramine causes topical pain relief through direct blockade of nociceptor sodium channels","volume":"35","author":"Hao","year":"2021","journal-title":"FASEB Journal: Off Publ Fed Am Societies For Exp Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.03.010","article-title":"Psychological stress and chronic urticaria: A neuro-immuno-cutaneous crosstalk. A systematic review of the existing evidence","volume":"42","author":"Konstantinou","year":"2020","journal-title":"Clin Ther"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.3390\/jcm12093134","article-title":"Neuro-immuno-psychological aspects of chronic urticaria","volume":"12","author":"Tomaszewska","year":"2023","journal-title":"J Clin Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S343462","article-title":"Cholinergic urticaria, an effective and safe \"off label\" use of dupilumab: A case report with literature review","volume":"15","author":"Sirufo","year":"2022","journal-title":"Clinical Cosmetic Investigational Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663626","article-title":"Nasal epithelial barrier integrity and tight junctions disruption in allergic rhinitis: Overview and pathogenic insights","volume":"12","author":"Husna","year":"2021","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.immuni.2022.09.016","article-title":"Interleukin-33-activated neuropeptide CGRP-producing memory Th2 cells cooperate with somatosensory neurons to induce conjunctival itch","volume":"55","author":"Okano","year":"2022","journal-title":"Immunity"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.01.028","article-title":"Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials","volume":"154","author":"Maurer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101529","article-title":"Basophils in antihelminth immunity","volume":"53","author":"Peng","year":"2021","journal-title":"Semin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.70286","article-title":"Altered immune profiles in non-failing heart donors with induced long QT syndrome: A potential risk factor for cardiac allograft vasculopathy","volume":"39","author":"Wen","year":"2025","journal-title":"Clin Transplant"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2023.133360","article-title":"Mediation of the JNC\/ILC2 pathway in DBP-exacerbated allergic asthma: A molecular toxicological study on neuroimmune positive feedback mechanism","volume":"465","author":"Xie","year":"2024","journal-title":"J Hazard Mater"},{"key":"B58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40981-023-00640-w","article-title":"General anesthetic management in two patients with an anaphylaxis history cholinergic urticaria","volume":"9","author":"Kotera","year":"2023","journal-title":"JA Clin Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16365","article-title":"Anhidrosis accompanied by cholinergic urticaria-like rash and dermal pain in a patient with sj\u00f6gren\u2019s syndrome","volume":"49","author":"Yanagida","year":"2022","journal-title":"J Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adc9417","article-title":"A mast cell-thermoregulatory neuron circuit axis regulates hypothermia in anaphylaxis","volume":"8","author":"Bao","year":"2023","journal-title":"Sci Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7301652","article-title":"Cholinergic urticaria: Clinical presentation and natural history in a tropical country","volume":"2020","author":"Rujitharanawong","year":"2020","journal-title":"BioMed Res Int"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2021.05.001","article-title":"Acetylcholine-induced whealing in cholinergic urticaria - what does it tell us","volume":"103","author":"Altrichter","year":"2021","journal-title":"J Dermatol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955161","article-title":"Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901851","article-title":"Evidence for histamine release in chronic inducible urticaria - a systematic review","volume":"13","author":"Kulthanan","year":"2022","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.36290\/csf.2024.002","article-title":"Chronic spontaneous urticaria, treatment with antihistamines","volume":"73","author":"Karlov\u00e1","year":"2024","journal-title":"Ceska A Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti A Slovenske Farmaceuticke Spolecnosti"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14460","article-title":"Lachnospira is a signature of antihistamine efficacy in chronic spontaneous urticaria","volume":"31","author":"Liu","year":"2022","journal-title":"Exp Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109198","article-title":"An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria","volume":"112","author":"Ornek","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.3390\/jcm10132980","article-title":"Variations of thiol-disulfide homeostasis parameters after treatment with H1-antihistamines in patients with chronic spontaneous urticaria","volume":"10","author":"Matei","year":"2021","journal-title":"J Clin Med"},{"key":"B69","first-page":"44","article-title":"Efficacy and safety of up-dosed second-generation antihistamines in uncontrolled chronic spontaneous urticaria: A review","volume":"16","author":"Podder","year":"2023","journal-title":"J Clin aesthetic Dermatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_7_25","article-title":"Effectiveness, safety, and tolerability of bilastine up-dosing in chronic spontaneous urticaria uncontrolled with licensed doses of other second-generation antihistamines-an institution-based, open-label, single-group longitudinal trial","volume":"17","author":"Chakraborty","year":"2026","journal-title":"Indian Dermatol Online J"},{"key":"B71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/biology11030433","article-title":"Pathobiology of second-generation antihistamines related to sleep in urticaria patients","volume":"11","author":"Mann","year":"2022","journal-title":"Biology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0649","article-title":"Efficacy and safety of up-dosing antihistamines in chronic spontaneous urticaria: A systematic review of the literature","volume":"31","author":"Sot\u00e9s","year":"2021","journal-title":"J Investigational Allergology Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-024-05315-w","article-title":"Approved therapies and their effects on the main symptoms of urticaria: When symptom control of itchy wheals is not adequate-does updosing help]","volume":"75","author":"Wieczorek","year":"2024","journal-title":"Dermatologie (Heidelberg Germany)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2025.07.021","article-title":"Management of chronic spontaneous urticaria made practical: What every clinician should know","volume":"13","author":"Kocat\u00fcrk","year":"2025","journal-title":"J Allergy Clin Immunol In Pract"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.12932\/AP-270820-0948","article-title":"Efficacy of drug therapies in antihistamine refractory chronic spontaneous urticaria: Real life data","volume":"42","author":"Unsel","year":"2024","journal-title":"Asian Pacific J Allergy Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14543","article-title":"Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment","volume":"34","author":"T\u00fcrk","year":"2021","journal-title":"Dermatologic Ther"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01537-w","article-title":"Fenebrutinib in h 1 antihistamine-refractory chronic spontaneous urticaria: A randomized phase 2 trial","volume":"27","author":"Metz","year":"2021","journal-title":"Nat Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000004298","article-title":"A new era in chronic spontaneous urticaria: FDA approval of the oral BTK inhibitor remibrutinib","volume":"88","author":"Jan","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2025.0733","article-title":"Rilzabrutinib in antihistamine-refractory chronic spontaneous urticaria: The RILECSU phase 2 randomized clinical trial","volume":"161","author":"Gim\u00e9nez-Arnau","year":"2025","journal-title":"JAMA Dermatol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/all.16598","article-title":"Anti-KIT barzolvolimab for chronic spontaneous urticaria","volume":"80","author":"Maurer","year":"2025","journal-title":"Allergy"},{"key":"B81","doi-asserted-by":"publisher","first-page":"S0091-6749(26)00129-6","DOI":"10.1016\/j.jaci.2026.02.018","article-title":"Randomized dose-finding study of anti-KIT barzolvolimab in patients with chronic spontaneous urticaria","volume":"24","author":"Metz","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae067","article-title":"Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: Results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial","volume":"191","author":"Altrichter","year":"2024","journal-title":"Br J Dermatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jaip.2020.07.058","article-title":"Canakinumab lacks efficacy in treating adult patients with moderate to severe chronic spontaneous urticaria in a phase II randomized double-blind placebo-controlled single-center study","volume":"9","author":"Maul","year":"2021","journal-title":"J Allergy Clin Immunol In Pract"},{"key":"B84","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2016.02.020","article-title":"The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves","volume":"138","author":"Feld","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2022.2042513","article-title":"Emerging treatments for chronic urticaria","volume":"31","author":"Wedi","year":"2022","journal-title":"Expert Opin Invest Drugs"},{"key":"B86","doi-asserted-by":"publisher","first-page":"10720","DOI":"10.3390\/ijms262110720","article-title":"The central role of Th2 immune response in inflammatory dermatoses: From pathogenesis to targeted therapies","volume":"26","author":"Pala","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01679-2","article-title":"Tezepelumab: first approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2025.1681375","article-title":"Co-existence of chronic spontaneous urticaria with atopic dermatitis: Clinical and immunological perspectives","volume":"6","author":"Toubi","year":"2025","journal-title":"Front Allergy"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.3390\/ijms25115972","article-title":"Thymic stromal lymphopoietin and tezepelumab in airway diseases: From physiological role to target therapy","volume":"25","author":"Bagnasco","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2138347","article-title":"Biologics for chronic spontaneous urticaria: Toward a personalized treatment","volume":"18","author":"Asero","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12016-025-09115-5","article-title":"Pathophysiologic mechanisms and targeted treatments associated with the nervous system in cutaneous allergic diseases","volume":"68","author":"Zhang","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/biom15050729","article-title":"The role of substance p in corneal homeostasis","volume":"15","author":"Jastrz\u0119bska-Miazga","year":"2025","journal-title":"Biomolecules"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01653-w","article-title":"Implications of nociceptor receptors and immune modulation: Emerging therapeutic targets for autoimmune diseases","volume":"33","author":"Fatima","year":"2025","journal-title":"Inflammopharmacology"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1654382","article-title":"Macrophages as central mediators of sympathetic neuro-immune interplay in autoimmunity","volume":"16","author":"Muntjewerff","year":"2025","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1735300","article-title":"Advances in intratumoral immunotherapy from a neuro-immune-endocrine perspective for breast cancer treatment","volume":"16","author":"Garay-Canales","year":"2026","journal-title":"Front Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156814","article-title":"Predictive cytokines of omalizumab in the treatment of chronic spontaneous urticaria","volume":"185","author":"Ji","year":"2025","journal-title":"Cytokine"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2026.100655","article-title":"Correlation between IL-17 levels and chronic urticaria: Systematic review and meta-analysis","volume":"5","author":"Wang","year":"2026","journal-title":"J Allergy Clin Immunol Global"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1643418","article-title":"Skin immune microenvironment in psoriasis: From bench to bedside","volume":"16","author":"Yao","year":"2025","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2026.101349","article-title":"What is new on the horizon for the biologics world: New kids of the block - WAO state of art","volume":"19","author":"Canonica","year":"2026","journal-title":"World Allergy Organ J"},{"key":"B100","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3892\/etm.2022.11309","article-title":"Immunological signature of chronic spontaneous urticaria (review)","volume":"23","author":"Dobrican","year":"2022","journal-title":"Exp Ther Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-025-01480-5","article-title":"Beyond antihistamines: How biologic and small-molecule therapies are transforming chronic spontaneous urticaria care in adults","volume":"45","author":"Bulkhi","year":"2025","journal-title":"Clin Drug Invest"},{"key":"B102","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaci.2022.01.028","article-title":"Mechanistic insights into the antipruritic effects of lebrikizumab, an anti-IL-13 mAb","volume":"150","author":"Miron","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14034","article-title":"Interleukin-4 and interleukin-13 evoke scratching behaviour in mice","volume":"28","author":"Campion","year":"2019","journal-title":"Exp Dermatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1014924","article-title":"Decreased peripheral basophil counts in urticaria and mouse model of oxazolone-induced hypersensitivity, the latter suggesting basopenia reflecting migration to skin","volume":"13","author":"Kishimoto","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1848638\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:14:42Z","timestamp":1780665282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1848638\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":104,"alternative-id":["10.3389\/fimmu.2026.1848638"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1848638","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"article-number":"1848638"}}